[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340449-105":59,"doc-detail-340449-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","structure-optimization-and-molecular-dynamics-studies-of-new-tumor-selective-s-triazines-targeting-dna-and-mmp-1013-for-halting-colorectal-and-secondary-liver-cancers","Structure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers","","A series of triazole-tethered triazines with DNA-targeting pharmacophoric features and non-hydroxamate MMP inhibitors were synthesized and evaluated in HCT-116 and Caco-2 cells and normal colonocytes using an MTT assay. Compounds 7a and 7g outperformed doxorubicin for potency and safety, while 7g was strong against HepG-2 liver cancer and correlated with MMP-13 expression. Both induced DNA damage, disrupted cell cycle progression, and triggered apoptosis, with docking and molecular dynamics supporting binding modes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/structure-optimization-and-molecular-dynamics-studies-of-new-tumor-selective-s-triazines-targeting-dna-and-mmp-1013-for-halting-colorectal-and-secondary-liver-cancers/340449/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/structure-optimization-and-molecular-dynamics-studies-of-new-tumor-selective-s-triazines-targeting-dna-and-mmp-1013-for-halting-colorectal-and-secondary-liver-cancers/340449.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were the triazole-tethered triazines evaluated for anticancer activity?","Question",{"text":112,"@type":113},"They were synthesized and screened against HCT-116 and Caco-2 cells and normal colonocytes using an MTT assay.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What key results distinguish compounds 7a and 7g from doxorubicin?",{"text":117,"@type":113},"7a and 7g surpassed doxorubicin in HCT-116 potency and safety, with 7g also showing strong activity against HepG-2 liver cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Which molecular mechanisms were reported for the lead compound 7g?",{"text":121,"@type":113},"The derivatives induced DNA damage, disrupted the HCT-116 cell cycle, triggered apoptosis, inhibited MMP-10/13, and downregulated HCT-116 VEGF related to CRC progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340449,1790865338,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Journal of EnzymE InhIbItIon and mEdIcInal chEmIstry 2024, Vol. 39, no. 1, 2423174  \n[https://doi.org/10.1080/14756366.2024.2423174](https://doi.org/10.1080/14756366.2024.2423174)  \nReseaRch aRticle  \nStructure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers  \nchristine a. Morcosa, Nesreen s. haibab, Rafik W. Bassilya, Marwa M. abu-seriec, amira F. el-Yazbid, Omar a. solimane, sherine N. Khattaba and Mohamed telebf,g  \nachemistry department, faculty of science, alexandria university, alexandria, Egypt; bdepartment of Physics and chemistry, faculty of Education, alexandria university, alexandria, Egypt; cmedical biotechnology department, Genetic Engineering and biotechnology research Institute, city of scientific research and technological applications (srta-city), new borg El-arab, Egypt; ddepartment of Pharmaceutical analytical chemistry, faculty of Pharmacy, alexandria university, alexandria, Egypt; edepartment of human Genetics, medical research Institute, alexandria university, alexandria, Egypt; fdepartment of Pharmaceutical chemistry, faculty of Pharmacy, alexandria university, alexandria, Egypt; gfaculty of Pharmacy, alamein International university (aIu), alamein city, Egypt  \nABSTRACT  \na series of triazole-tethered triazines bearing pharmacophoric features of DNa-targeting agents and non-hydroxamate MMPs inhibitors were synthesized and screened against hct-116, caco-2 cells, and normal colonocytes by Mtt assay. 7a and 7g surpassed doxorubicin against hct-116 cells regarding potency (ic50 = 0.87 and 1.41 nM) and safety (si = 181.93 and 54.41). 7g was potent against liver cancer (hepG-2; ic50 = 65.08 nM), the main metastatic site of cRc with correlation to MMP-13 expression. Both derivatives induced DNa damage at 2.67 and 1.87 nM, disrupted hct-116 cell cycle and triggered apoptosis by 33.17% compared to doxorubicin (DNa damage at 0.76 nM and 40.21% apoptosis induction). 7g surpassed NNGh against MMP-10 (ic50 = 0.205 μM) and MMP-13 (ic50 = 0.275 μM) and downregulated hct-116 VeGF related to cRc progression by 38%. Docking and MDs simulated ligands-receptors binding modes and highlighted saR. their aDMet profiles, drug-likeness and possible off-targets were computationally predicted.  \nGRAPHICAL ABSTRACT  \nARTICLE HISTORY  \nreceived 27 october 2023 revised 20 october 2024 accepted 24 october 2024  \nKEYWORDS  \ncolorectal cancer; dna targeting; mmP-10/13 inhibition; 1,2,3-triazoletethered s-triazines; molecular dynamics  \nCONTACT sherine n. Khattab  [sherinekhattab@alexu.edu.eg](sherinekhattab@alexu.edu.eg), [sh.n.khattab@gmail.com](sh.n.khattab@gmail.com)  chemistry department, faculty of science, alexandria university,  \nalexandria 21321, Egypt; mohamed teleb  [mohamed.t.ismail@alexu.edu.eg](mohamed.t.ismail@alexu.edu.eg), [mismail@aiu.edu.eg](mismail@aiu.edu.eg)  department of Pharmaceutical chemistry, faculty of Pharmacy,  \nalexandria university, alexandria 21521, Egypt, and faculty of Pharmacy, alamein International university (aIu), alamein city, alamein city 5060310, Egypt  supplemental data for this article can be accessed online at [https://doi.org/10.1080/14756366.2024.2423174](https://doi.org/10.1080/14756366.2024.2423174)  \n© 2024 the author(s) . Published by Informa uK limited, trading as taylor & francis Group  \nthis is an open access article distributed under the terms of the creative commons attribution-noncommercial license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. the terms on which this article has been published allow the posting of the accepted manuscript in a repository by the author(s) or with their consent.  \n2  c. a. MORcOs et al.  \nIntroduction  \ncancer continues to be a barrier to increased hum","cbCaifc1ASJpoZid","https://ap.wps.com/l/cbCaifc1ASJpoZid","pdf",4614043,31,"English","# Introduction\n## DNA as a cancer therapy target\n## DNA-binding agents and multitarget strategies","[{\"question\":\"How were the triazole-tethered triazines evaluated for anticancer activity?\",\"answer\":\"They were synthesized and screened against HCT-116 and Caco-2 cells and normal colonocytes using an MTT assay.\"},{\"question\":\"What key results distinguish compounds 7a and 7g from doxorubicin?\",\"answer\":\"7a and 7g surpassed doxorubicin in HCT-116 potency and safety, with 7g also showing strong activity against HepG-2 liver cancer.\"},{\"question\":\"Which molecular mechanisms were reported for the lead compound 7g?\",\"answer\":\"The derivatives induced DNA damage, disrupted the HCT-116 cell cycle, triggered apoptosis, inhibited MMP-10/13, and downregulated HCT-116 VEGF related to CRC progression.\"}]","Structure optimization and molecular dynamics studies of new tumor-selective s-triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers | PDF",1790036599,78,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/deaa580254ecb4667c8d1efde8f40447.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fef86ee010be254066df52557c98841.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a990605ce0c8e049ba3ddfab58c6127.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9995be65a0d3aa6cd9a90d07e137822.webp",980,1268]